Ebola Outbreak 2026: DRC Cases Surpass 5,600 as Fastest-Spreading Epidemic on Record Continues

Ebola Outbreak 2026: DRC Cases Surpass 5,600 as Fastest-Spreading Epidemic on Record Continues

The Ebola outbreak in the Democratic Republic of the Congo (DRC) has now surpassed 5,600 confirmed cases, making it the fastest-spreading Ebola epidemic ever recorded and the second-largest in history. As of August 24, 2026, the DRC has reported 5,656 confirmed cases and 2,715 deaths — and the numbers are still climbing rapidly, with 72 new cases and 35 deaths confirmed in a single 24-hour period.

The outbreak, caused by the rare Bundibugyo virus, a type of ebolavirus, is spreading across six provinces of northeastern DRC and has already triggered international concern, with imported cases reported in Germany, France, and the United States. Public health agencies including the World Health Organization (WHO), the U.S. Centers for Disease Control and Prevention (CDC), and the European Centre for Disease Prevention and Control (ECDC) are closely monitoring what they describe as a rapidly evolving global health situation.

Outbreak at a Glance: Key Numbers

• 5,656 confirmed cases in the DRC as of 24 August 2026
• 2,715 deaths, with roughly half of all fatalities reported in the last 20 days alone
• 792 patients currently hospitalized in isolation units
• 1,245 people recovered and discharged after testing positive for Bundibugyo virus
• 58 of 151 health zones across six provinces now affected
• 20 cases and 2 deaths reported in Uganda, which declared itself Ebola-free on 28 July 2026

Why This Outbreak Is Different

The current epidemic is caused by the Bundibugyo virus, a rare species of ebolavirus that has no approved vaccine or specific treatment. Most previous Ebola outbreaks — including the devastating 2014–2016 West Africa epidemic that killed around 11,000 people — were caused by the Zaire strain, for which the Merck Ervebo vaccine is licensed.

According to the UN’s senior Ebola coordinator, Julien Harneis, the epidemic is “growing exponentially” and already covers an area larger than France. It is expanding roughly three times faster than the 2014–2016 West Africa outbreak, making it the fastest-spreading Ebola epidemic on record and the deadliest in the DRC’s history.

Where the Virus Is Spreading

The first infections were detected earlier this year in the DRC’s northeastern Ituri province, a region where armed groups operate and health infrastructure is limited. Congolese authorities officially declared the outbreak on May 15, 2026, though experts believe the virus had been circulating for some time before that announcement.

Since then, the outbreak has spread to five additional provinces:

• Ituri — the worst-hit province, with 4,716 cases and 2,119 deaths across 28 of 36 health zones
• North Kivu — 735 cases and 501 deaths across 13 of 34 health zones
• Haut-Uélé — 184 cases and 85 deaths
• Tshopo — 15 cases and 8 deaths
• South Kivu — 3 cases and 1 death
• Bas-Uélé — 3 cases and 1 death

The outbreak also reached Uganda’s capital, Kampala, where 20 confirmed cases and 2 deaths were reported. Uganda discharged its last Ebola patient on July 16, 2026, and officially declared the end of its outbreak on July 28, 2026.

International Cases and Global Response

While transmission remains concentrated in Central Africa, the outbreak has already produced imported cases abroad:

• May 2026: A U.S. citizen was medically evacuated from the region to Germany for treatment.
• June 24, 2026: France reported an imported case in a humanitarian doctor returning from the affected area.
• July 10, 2026: The CDC reported that a U.S. citizen humanitarian worker had tested positive for Bundibugyo virus and was evacuated to Germany on July 13.

The WHO has announced the immediate release of 70,000 doses of Merck’s Ervebo Ebola vaccine to the DRC. Although Ervebo is only approved for the Zaire strain, early animal data suggests it may offer some cross-protection against Bundibugyo. The allocation includes 20,000 doses for a Phase 3 clinical trial studying the vaccine’s impact on the Bundibugyo virus, and 50,000 doses for frontline and health workers.

The CDC reports that around 500 staff members are involved in the outbreak response, including more than 120 people deployed to affected countries. The ECDC assesses the risk of infection for people living in the European Union and European Economic Area as very low, while continuing to monitor the situation closely.

Symptoms and How Ebola Spreads

Ebola is transmitted between people through direct contact with bodily fluids of an infected person, or with contaminated surfaces and materials. It is not airborne.

Symptoms typically begin with:

• Sudden fever and chills
• Severe fatigue and weakness
• Muscle pain and headache
• Sore throat

As the illness progresses, patients may develop:

• Vomiting and diarrhea
• Rash and impaired kidney and liver function
• In some cases, internal and external bleeding

Early supportive care — including fluid and electrolyte replacement and treatment of symptoms — significantly improves survival. That is why health authorities stress the importance of rapid case identification, isolation, and contact tracing.

What This Means for Travelers

The CDC has issued guidance for people who have recently been in areas affected by the outbreak, including the DRC, Uganda, and South Sudan. Travelers returning from affected regions should:

• Monitor their health for 21 days after return
• Seek medical attention immediately if fever or Ebola symptoms develop
• Inform healthcare providers of their travel history before attending clinics

Health officials warn that without urgent scaling of resources and funding, the epidemic will spread wider and risks spilling into neighboring countries. “If we do not [act], this epidemic will become more deadly. It will spread wider and it risks to spread into neighboring countries,” Harneis cautioned.

Frequently Asked Questions

What is the Bundibugyo virus?

Bundibugyo virus is one of several species of ebolavirus that cause Ebola disease in humans. It was first identified in Uganda in 2007 and is rarer than the Zaire strain. Unlike Zaire ebolavirus, there is currently no approved vaccine or specific antiviral treatment for Bundibugyo virus infection.

How big is the current DRC Ebola outbreak?

As of August 24, 2026, the DRC has reported 5,656 confirmed cases and 2,715 deaths, making it the second-largest Ebola outbreak on record and the fastest-spreading ever documented.

Is there a vaccine for this Ebola strain?

The licensed Ervebo vaccine is approved for the Zaire strain of Ebola. Because of the current outbreak, the WHO is releasing 70,000 Ervebo doses to the DRC — including 50,000 for frontline workers and 20,000 for a Phase 3 trial — based on early animal data suggesting possible cross-protection against Bundibugyo.

Should travelers be worried?

The risk to the general public outside affected regions remains very low. The virus spreads only through direct contact with bodily fluids of symptomatic patients. Travelers returning from affected areas should monitor for symptoms for 21 days and seek care if they develop a fever.

How is Ebola treated?

There is no specific cure for Ebola, but supportive care — intravenous fluids, oxygen, blood pressure management, and treatment of secondary infections — dramatically improves survival. Early diagnosis and isolation are critical to both patient outcomes and outbreak control.

Bottom Line

The DRC’s Bundibugyo virus outbreak is a public health emergency of serious concern, spreading faster than any Ebola epidemic in history. While the risk outside Central Africa remains low, the window for containing the outbreak is narrowing. Health agencies are calling for urgent international support to scale up vaccination, treatment capacity, and community surveillance before the virus expands further — and before it spills across more borders.

Health Professional Radio will continue to monitor this developing story and provide updates as new information emerges from the WHO, CDC, ECDC, and national health ministries.